ArticleStructural heart : the journal of the Heart Team2025
Impact of Basal Septal Bulge on Conduction Disturbance After Transcatheter Aortic Valve Replacement Using ACURATE neo/neo2.
Article in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: New-onset conduction disturbance (CD) is a common complication of transcatheter aortic valve replacement (TAVR). Recently, basal septal bulge (BSB) has been reported as a predictor of CD. However, the impact of BSB on CD using ACURATE neo/neo2 remains unclear. We hypothesized that the left bundle branch could be damaged in patients with large BSB even by low radial force. This study investigated the predictors of CD after TAVR using ACURATE neo/neo2 and the impact of BSB on CD. Methods: We retrospectively analyzed 518 patients who underwent TAVR with ACURATE neo/neo2 in a single center. New-onset CD was defined as 30-day new permanent pacemaker implantation or new left bundle branch block lasting until discharge. The endpoints were the predictors of CD and the effect of BSB. Results: The incidence of CD was 11.0%. Multivariate analysis showed that complete right bundle branch block (odds ratio [OR]: 3.45; 95% CI: 1.63-7.30), membranous septum length <2 mm (OR: 2.14; 95% CI: 1.19-3.85), and BSB ≥3 mm (OR: 2.17; 95% CI: 1.22-3.86) were independent baseline predictors of CD. Postdilatation was the sole procedural predictor (OR: 2.28; 95% CI: 1.03-5.02). The risk of CD could be stratified according to the number of baseline predictors in patients with BSB ≥3 mm (0: 9.5%, 1: 26.1%, 2: 66.7%, Conclusions: BSB was significantly associated with CD in ACURATE neo/neo2, and CD risk could be stratified using baseline factors in patients with large BSB. These findings might be beneficial for periprocedural management and TAVR strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.